Geron | GERN - Assets

Stock Price
1.66
Daily Change
0.08 4.75%
Monthly
-8.06%
Yearly
-4.89%
Q1 Forecast
1.53

Geron reported $570.54M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Amgen USD 90.59B 445M Dec/2025
Bio Techne USD 2.52B 3.45M Dec/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Cytokinetics USD 1.42B 12.02M Dec/2025
Esperion Therapeutics USD 465.89M 101.87M Dec/2025
Exelixis USD 2.84B 20.87M Dec/2025
Genmab DKK 6.46B 122M Jun/2025
Geron USD 570.54M 3.16M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novavax USD 1.18B 156.66M Sep/2025